Anixa Biosciences (ANIX) CEO purchases 5,000 company shares
Rhea-AI Filing Summary
Anixa Biosciences Inc director and Chief Executive Officer Amit Kumar purchased 5,000 shares of common stock in an open-market transaction on July 31, 2026, at $3.47 per share. After this purchase, he directly holds 657,000 shares of Anixa Biosciences common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 5,000 shares
Net Buy
1 txn
Insider
KUMAR AMIT
Role
Chief Executive Officer
Bought
5,000 shs ($17K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 5,000 | $3.47 | $17K |
Holdings After Transaction:
Common Stock — 657,000 shares (Direct)
Key Figures
Shares Purchased: 5,000 shares
Purchase Price: $3.47 per share
Shares Owned After: 657,000 shares
+2 more
5 metrics
Shares Purchased
5,000 shares
Common stock bought by Amit Kumar on 2026-07-31
Purchase Price
$3.47 per share
Price per share for the common stock purchase
Shares Owned After
657,000 shares
Direct common stock holdings of Amit Kumar after the transaction
Transaction Code
P
Indicates an open-market or private purchase of non-derivative securities
Transaction Date
2026-07-31
Date of the reported common stock purchase
Key Terms
non-derivative, open market or private transaction, Rule 10b5-1, direct or indirect ownership
4 terms
non-derivative financial
"transaction_type": "non-derivative" for the common stock trade"
open market or private transaction financial
"transaction_code_description": "Purchase in open market or private transaction""
Rule 10b5-1 regulatory
"The Rule 10b5-1 trading plan checkbox (aff_10b5_one) is marked false"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
direct or indirect ownership financial
"direct_or_indirect uses D/I for Direct or Indirect ownership type"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider purchase did Anixa Biosciences (ANIX) CEO Amit Kumar make?
Amit Kumar purchased 5,000 shares of Anixa Biosciences common stock at $3.47 per share on July 31, 2026. Following this open-market transaction, his direct ownership increased to 657,000 shares of the company’s common stock.
When did the recent Anixa Biosciences (ANIX) insider transaction occur?
The reported insider purchase took place on July 31, 2026. On that date, CEO Amit Kumar acquired 5,000 shares of Anixa Biosciences common stock in an open-market transaction at a price of $3.47 per share.
What was the price paid in the latest Anixa Biosciences (ANIX) insider buy?
The shares were purchased at $3.47 per share. CEO Amit Kumar acquired 5,000 shares of Anixa Biosciences common stock at this price in an open-market transaction dated July 31, 2026, increasing his direct holdings to 657,000 shares.
Was the Anixa Biosciences (ANIX) insider transaction made under a Rule 10b5-1 plan?
The Rule 10b5-1 trading plan checkbox is marked false, indicating the transaction was not affirmed as made under a Rule 10b5-1 plan. The purchase is reported as an open-market acquisition of 5,000 shares at $3.47 per share.